LEXISCAN(R) (REGADENOSON)

CHEBI:CHEBI_748735

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
listing_expiration_date
20251231
marketing_start_date
20191210
package_marketing_start_date
20191210
dosage_form
INJECTION, SOLUTION
route
INTRAVENOUS
nui
N0000175788
pharm_class_epc
Adenosine Receptor Agonist [EPC]
pharm_class_moa
Adenosine Receptor Agonists [MoA]
pharm_class
Pharmacologic Cardiac Stress Test Agent [EPC]
active_ingredient_name
REGADENOSON
active_ingredient_strength
.08 mg/mL
labeler_name
HF Acquisition Co LLC, DBA HealthFirst
manufacturer_name
HF Acquisition Co LLC, DBA HealthFirst
generic_name
LEXISCAN(R) (REGADENOSON)
brand_name
LEXISCAN(R) (REGADENOSON)
brand_name_base
LEXISCAN(R) (REGADENOSON)
product_ndc
51662-1448
application_number
NDA022161
spl_id
0ffbfae4-66b6-b616-e063-6294a90a2d06
package_ndc
51662-1448-1
package_description
1 SYRINGE, PLASTIC in 1 CARTON (51662-1448-1) / 5 mL in 1 SYRINGE, PLASTIC
unii
2XLN4Y044H
spl_set_id
99640071-4db2-9317-e053-2995a90a610d
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class